OtherBasic Science (Animal or Phantoms)
Open Access
Development of novel FAP-targeted radiotracers with improved tumor retention
Anastasia Loktev, Thomas Lindner, Eva-Maria Burger, Annette Altmann, Frederik Giesel, Clemens Kratochwil, Juergen Debus, Frederik Marme, Dirk Jaeger, Walter Mier and Uwe Haberkorn
Journal of Nuclear Medicine March 2019, jnumed.118.224469; DOI: https://doi.org/10.2967/jnumed.118.224469
Anastasia Loktev
1 University Hospital Heidelberg, Germany;
Thomas Lindner
1 University Hospital Heidelberg, Germany;
Eva-Maria Burger
1 University Hospital Heidelberg, Germany;
Annette Altmann
1 University Hospital Heidelberg, Germany;
Frederik Giesel
1 University Hospital Heidelberg, Germany;
Clemens Kratochwil
1 University Hospital Heidelberg, Germany;
Juergen Debus
1 University Hospital Heidelberg, Germany;
Frederik Marme
1 University Hospital Heidelberg, Germany;
Dirk Jaeger
1 University Hospital Heidelberg, Germany;
Walter Mier
1 University Hospital Heidelberg, Germany;
Uwe Haberkorn
2 University Hospital Heidelbergn, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
Development of novel FAP-targeted radiotracers with improved tumor retention
Anastasia Loktev, Thomas Lindner, Eva-Maria Burger, Annette Altmann, Frederik Giesel, Clemens Kratochwil, Juergen Debus, Frederik Marme, Dirk Jaeger, Walter Mier, Uwe Haberkorn
Journal of Nuclear Medicine Mar 2019, jnumed.118.224469; DOI: 10.2967/jnumed.118.224469
Development of novel FAP-targeted radiotracers with improved tumor retention
Anastasia Loktev, Thomas Lindner, Eva-Maria Burger, Annette Altmann, Frederik Giesel, Clemens Kratochwil, Juergen Debus, Frederik Marme, Dirk Jaeger, Walter Mier, Uwe Haberkorn
Journal of Nuclear Medicine Mar 2019, jnumed.118.224469; DOI: 10.2967/jnumed.118.224469
Jump to section
Related Articles
Cited By...
- Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies
- Toward Quantitative Multisite Preclinical Imaging Studies in Acute Myocardial Infarction: Evaluation of the Immune-Fibrosis Axis
- Characterizing Normal Variant [68Ga]Ga-FAPI-46 Uptake in the Epididymis
- Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein {alpha}
- PET imaging of fibroblast activation protein alpha (FAP) detects incipient cardiotoxicity due to anthracycline chemotherapy
- Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
- Tumor Characterization by [68Ga]FAPI-46 PET/CT Can Improve Treatment Selection for Pancreatic Cancer Patients: An Interim Analysis of a Prospective Clinical Trial
- Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
- Fibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions
- 68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
- Fibroblast Activation Protein-Targeted Radioligand Therapy for Treatment of Solid Tumors
- Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
- Three-Time-Point PET Analysis of 68Ga-FAPI-46 in a Variety of Cancers
- PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study
- A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
- Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
- Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
- Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in Mice
- Correlation of 68Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
- Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
- Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
- Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
- 68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
- Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study
- Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
- FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?
- Fibroblast Activation Protein-Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT
- The Latest Developments in Imaging of Fibroblast Activation Protein
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18F-Labeled FAP Inhibitor
- Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy
- Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
- Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
- FAP: The Next Billion Dollar Nuclear Theranostics Target?